Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-25-003501

President and CEO acquired 500,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stergiou Angelos M. President and CEO 2025-01-10 Grant or award +257,000 615,132 D
Stergiou Angelos M. President and CEO 2025-01-10 Grant or award +243,900 859,032 D
Derivatives
Stergiou Angelos M. President and CEO 2025-01-10 Grant or award · Stock Option (Right to Buy) +385,750 385,750 D
Loading xslF345X05/tm253166-7_4seq1.xml…